Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational study

OBJECTIVES: To describe and quantify disclosed payments from the pharmaceutical industry to the healthcare sector, and to examine the impact of the 2015 changes to Australia’s self-regulated system of transparency. DESIGN: Observational database study. SETTING: Australia. PARTICIPANTS: Publicly avai...

Descripción completa

Detalles Bibliográficos
Autores principales: Parker, Lisa, Karanges, Emily A, Bero, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Health Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377522/
https://www.ncbi.nlm.nih.gov/pubmed/30782921
http://dx.doi.org/10.1136/bmjopen-2018-024928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377522/
https://www.ncbi.nlm.nih.gov/pubmed/30782921
http://dx.doi.org/10.1136/bmjopen-2018-024928

Ejemplares similares